SALV Salvarx Group Plc

TIDMSALV

RNS Number : 2703M

FTSE Russell

04 January 2019

Salvarx Group (UK): Constituent Deletion

Changes in FTSE UK Index Series

04 January 2019

 
 Subject to completion of the transaction with Portage Biotech (non-constituent) and the subsequent 
  re-classification to AIM Rule 15 (cash shell) for Salvarx Group (UK, constituent), please 
  see details of affected indexes and effective dates below: 
 
 
          Index              Effective From 
                             Start of Trading 
 FTSE AIM All-Share Index   09 January 2019 
 
 
 
 
 
 For further information please contact FTSE Russell Client Services at info@ftserussell.com 
                             or call: Australia    +1800 653 680 
                                  Hong Kong    +852 2164 3333 
                                 Japan        +81 3 4563 6346 
                               London       +44 (0) 20 7866 1810 
                                  New York     +1866 551 0617 
 
                Alternatively please visit our website at www.ftserussell.com 
                        Terms of Use | Copyright (c) 2019 FTSE Russell 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

FTSXZLFBKFFLBBX

(END) Dow Jones Newswires

January 04, 2019 12:30 ET (17:30 GMT)

Salvarx (LSE:SALV)
Historical Stock Chart
From Mar 2024 to Apr 2024

Salvarx (LSE:SALV)
Historical Stock Chart
From Apr 2023 to Apr 2024